Track Blau Farmacêutica S.A.'s receivables ($630M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Blau Farmacêutica S.A. posts a receivables of $630M as of September 2026. That compares with $520M in the prior-year period — up 20.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Blau Farmacêutica S.A.'s receivables was $520M. The latest reading is $630M — a 20.3% year-over-year increase (period ending September 2026). Use the history and growth charts on this page for a longer lookback.
Receivables is one piece of Blau Farmacêutica S.A.'s financial statement story. At $630M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for BLAU3.SA's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Blau Farmacêutica S.A.'s other metric pages and overview cover the third.